» Articles » PMID: 22634495

MicroRNA-10a Targets CHL1 and Promotes Cell Growth, Migration and Invasion in Human Cervical Cancer Cells

Overview
Journal Cancer Lett
Specialty Oncology
Date 2012 May 29
PMID 22634495
Citations 71
Authors
Affiliations
Soon will be listed here.
Abstract

MicroRNAs (miRNAs) play an important role in cancer initiation, progression and metastasis by regulating their target genes. Here, we found microRNA-10a (miR-10a) is upregulated in human cervical cancer and promotes the colony formation activity, migration and invasion of HeLa and C33A cells. Subsequently, CHL1 is confirmed as a target of miR-10a and is negatively regulated by miR-10a at mRNA and protein levels. Furthermore, knockdown of CHL1 expression results in increased colony formation activity, migration and invasion. Finally, overexpression of CHL1 lacked the 3'UTR abolished the effects of miR-10a. Our results may provide a strategy for blocking tumor metastasis.

Citing Articles

Up-regulation of miR-10a-5p expression inhibits the proliferation and differentiation of neural stem cells by targeting .

Zhang J, Yang L, Sun Y, Zhang L, Wang Y, Liu M Acta Biochim Biophys Sin (Shanghai). 2024; 56(10):1483-1497.

PMID: 38841745 PMC: 11532229. DOI: 10.3724/abbs.2024078.


MiRNA in cervical cancer: Diagnosis to therapy: Systematic review.

Endale H, Mariye Y, Negash H, Hassen F, Asrat W, Mengstie T Heliyon. 2024; 10(3):e24398.

PMID: 38317930 PMC: 10839805. DOI: 10.1016/j.heliyon.2024.e24398.


Role of extracellular vesicle in human papillomavirus-associated cervical cancer.

Dong S, Zhang Y, Wang Y J Cancer Res Clin Oncol. 2023; 149(17):16203-16212.

PMID: 37668793 DOI: 10.1007/s00432-023-05374-x.


Transcriptomic analyses of ovarian clear-cell carcinoma with concurrent endometriosis.

Collins K, Wang X, Klymenko Y, Davis N, Martinez M, Zhang C Front Endocrinol (Lausanne). 2023; 14:1162786.

PMID: 37621654 PMC: 10445169. DOI: 10.3389/fendo.2023.1162786.


Recent Updates on the Role of the MicroRNA-10 Family in Gynecological Malignancies.

Li C, Zhu X, Lv X, Han X, Xu Y, Huang J J Oncol. 2022; 2022:1544648.

PMID: 36578791 PMC: 9792234. DOI: 10.1155/2022/1544648.